SOLENO THERAPEUTICS INC (SLNO) Form 8-K — May 18, 2026
$SLNOForm 8-KItems 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01Filed May 18, 2026, 9:06 AM ET0001193125-26-228016Original filing
Soleno Therapeutics, Inc. completed its merger with Neurocrine Biosciences, Inc. on May 18, 2026, following a tender offer that expired on May 15, 2026. Approximately 88.9% of outstanding shares (46,356,114 shares) were tendered at the offer price of $53.00 per share, satisfying the minimum condition for the transaction.
Key figures
- Deal Value Usd
- 2.458 billion
- Offering Price
- 53
- Shares Offered
- 46,356,114
- Merger date
- 2026-05-18
- Tendered shares
- 46,356,114
- Offer expiration
- 2026-05-15
- Tendered percentage
- 88.9%
Price after filing
1 day: 0.0%7 days: +0.0%
Close on the filing date to close N calendar days later (from $52.99). Historical, not a forecast.
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.